Results 31 to 40 of about 4,792,921 (311)
Background Hyperparathyroidism jaw‐tumor syndrome (HPT‐JT) is the rarest familial cause of primary hyperparathyroidism, with an incidence
Guilhaume Garrigues+10 more
doaj +1 more source
Primary hyperparathyroidism and hypertension.
Although untreated primary hyperparathyroidism is associated with increased cardiovascular mortality, controversy exists regarding the therapeutic effects of parathyroidectomy on cardiovascular health.
S. Fisher, N. Perrier
semanticscholar +1 more source
Hypercalcaemia and its systemic sequelae are a relatively common finding amongst patients in the field of endocrinology. Primary hyperparathyroidism, a frequent cause of hypercalcaemia, is often seen among middle-aged female patients, typically resulting
Maxim Barnett+4 more
doaj +1 more source
Osseous Manifestations of Primary Hyperparathyroidism: Imaging Findings
Primary hyperparathyroidism is a systemic endocrine disease that has significant effects on bone remodeling through the action of parathyroid hormone on the musculoskeletal system.
J. Bennett, J. Suliburk, F. Morón
semanticscholar +1 more source
Primary Hyperparathyroidism [PDF]
none
MARCOCCI, CLAUDIO, Cetani, Filomena
openaire +7 more sources
Parathyroid adenoma: multimodal diagnosis capabilities: A retrospective study
Background. Primary hyperparathyroidism is a common endocrinological disease caused mainly by parathyroid adenoma. The main treatment method is surgery (parathyroidectomy). Therefore, the exact determination of adenoma localization is crucial. Aim. To
Nikolai A. Ognerubov+2 more
doaj +1 more source
Importance Primary hyperparathyroidism (pHPT) is a common clinical problem for which the only definitive management is surgery. Surgical management has evolved considerably during the last several decades. Objective To develop evidence-based guidelines
S. Wilhelm+15 more
semanticscholar +1 more source
Unmasking of Normocalcemic Primary Hyperparathyroidism After Sodium-Glucose Cotransporter-2 Inhibitor Initiation. [PDF]
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have complex interactions with bone metabolism, including an increase in parathyroid hormone (PTH) levels.
Dolapsakis C+2 more
europepmc +2 more sources
Differential Diagnosis of Primary and Secondary Hyperparathyroidism Caused by Vitamin D Deficiency
Causes of secondary increase of parathyroid hormone, especially vitamin D deficiency, can significantly interfere with the diagnosis of hyperparathyroidism.
S.M. Cherenko, H.V. Bandura
doaj +1 more source
Successful Treatment of Osteitis Fibrosa Cystica from Primary Hyperparathyroidism
Osteitis Fibrosa Cystica (OFC) is defined as the classic skeletal manifestation of advanced primary hyperparathyroidism. With the increased detection by means of routine calcium screening, the clinical profile of primary hyperparathyroidism in Western ...
Anthony M. Maina, Harry Kraus
doaj +1 more source